The purpose of the study is to evaluate the safety and effectiveness of the ReliantHeart HeartAssist 5® VAD System in patients listed for heart transplantation and at risk of death from refractory end-stage heart failure.
CRITERIA LIST/ QUALIFICATIONS:
Body Surface Area (BSA) ≥ 1.2 m2.
Cardiac transplant candidate.
LVAD implantation has been approved by the institution's multidisciplinary transplant committee.